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Introduction
Cancer is defined as rapid development of abnormal 
cells that can spread to other organs (Neda Amoori, 2014; 
Ghoncheh et al., 2015; Keyghobadi, 2015). It is one of 
the leading causes of death in developed and developing 
countries (Bryere, 2014; Keyghobadi, 2015; Razi et al., 
2015). In the past decades, unhealthy lifestyle was an 
important risk factor in western countries and currently 
the factor increased cancer in developing countries(Jemal, 
2010). Furthermore, increasing life expectancy and aging 
population are other important factors for enhancing 
cancer incidence in these countries (Thun, 2010; 
Keyghobadi, 2015) so that the burden of disease has 
increased more than twice (Harirchi, 2011). 
According to epidemiological and demographic 
transition of population and changed patterns of 
mortality in Iran, cancer is the third cause of death after 
cardiovascular diseases and accidents (Kolahdoozan et 
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Abstract
 Background: Cancer is a leading cause of death throughout the world. Increasing life expectancy and aging 
population are important factors for increasing cancer incidences in developing countries. National programs are 
essential for prevention and control of cancer in any society. This study aimed to investigate cancer epidemiology 
and trends in the province of Hamadan, located in Northwest Iran. Materials and Methods: This analytical 
study was carried out based on cancer registry data from 2004 to 2009 in the province of Hamadan, analyzed 
using STATA (version 12) software for descriptive tests and Join point 4.1.1.1 software for analytical tests. 
Results: There were 7,767 registered cases of cancer during the 6 years studied. Of the total cases registered, 
59.1% (4,592 cases) involved men and 40.9% (3,175 cases) occurred in women. Age-standardized incidence 
rates (ASR) increased from 72.9 to 132.0 in males and 48.2 to 115.0 in females during the 6 years of the study 
(p<0.001). The most common cancers were skin, stomach, breast, bladder, and leukemia. In women, teh most 
common were breast, skin, stomach, colorectal, and leukemia, in that order, and in men skin, stomach, bladder, 
leukemia, and prostate cancers. Conclusions: The cancer incidence is greater in men that women in this region 
but with increasing trends in both sexes. Planning regarding education in prevention of exposure to risk factors 
and control strategies is required to decrease the incident cases. Screening programs for common cancers in 
older age groups might be helpful to reduce the disease impact. 
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al., 2010). Therefore, national programs are essential for 
prevention and control of cancer in any society. Cancer 
registry is considered as a main tool for management and 
control of the disease (Goya, 2007). In population based 
cancer registries, there is data collected from cancer 
incidence and mortality from the disease obtained from 
a target group to describe epidemiology of cancer in a 
defined region (Zanetti and Chen, 2013), plan cancer 
control strategies, conduct, and evaluate cancer prevention 
and control effects by scientific research. Cancer statistics 
is widely used in scientific studies, clinical trials, and 
making decisions on cancer prevention and control (Chen, 
2013). 
The primary purposes of cancer control programs is 
early detection, effective treatment, and palliative care 
programs, in which target population is not limited to 
certain age, sex, ethnicity, and race (Goya, 2007). Since 
knowing disease status in any society is necessary to 
prevention planning and cancer control, especially in high 
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prevalence areas, this study aimed to investigate cancer 
epidemiology and trend in the province of Hamadan, 
located in North West of Iran.. 
Materials and Methods
 This was an analytical study carried out based on 
cancer registry data and the disease management center 
of health ministry from 2004 to 2009 in the province of 
Hamadan. Data used in this study was obtained from a 
national registry of cancer (NCR), and Disease Control 
and Prevention (CDC) of ministry of Health and Medical 
Education in Iran for 2004 to 2009 in Iran, there are 30 
provinces and 41 Medical Universities. Deputy for health 
of each university is responsible for health issues of the 
population and all health activities are managed by these 
deputies. All deputies for health have been included in 
the NCR. Registrar would apply the national registration 
software which was developed by CDC. For pathologic 
centers, without software, the cancer records were 
gathered manually. The Cancer Office of CDC should 
provide techniques and funding supports. The data are 
transmitted every 3 months, by electronic file and also 
hard copy of ‘Cancer Registry Data Collection Form’; 
this form is comprised of three parts: part I, regarding 
patient’s identity characteristics in addition to the name 
of biopsy-taker physician, name of hospital, location of 
which the biopsy is taken, clinical diagnosis and date of 
biopsy sent to histological laboratory and demographic 
information of the patients includes race and residence. 
Part II includes the most important findings of patient’s 
clinical history. Part III includes preclinical findings. 
The information includes primary location of tumor, date 
of cancer diagnosis, morphology and histology and its 
behavior and diagnosis method. Physicians fill the form 
of clinical data and the official personnel fill the identity 
and demographic information. Quality control has been 
coordinated in five main areas by Cancer Office of CDC: 
(i) regarding completeness of coverage; (ii) completeness 
of details; (iii) accuracy of data; (iv) accuracy of reports; 
(v) accuracy of interpretation and (vi) repeated cases are 
deleted from national data. Surveillance of pathology is 
based on the cancer record in several selected provinces 
to compare it with the present pathology cancer record 
for a general and complete evaluation and also for the 
accuracy of the collected data. IARC software provides a 
way to identify inaccuracies in data coding. Accordance of 
The International Classification of Diseases for Oncology 
(ICD-OC: topography with ICD-OM: morphology) 
is done manually and also by considering age and sex 
groups (pathology file of fatal error has been revised by 
the Scientific Society of Pathology of Iran and also by two 
masters in pathology).
 Method for deleting repeated cases: for the lack 
of any classified National Identification Numbers, the 
process for deleting the repeated cases was completed 
by a manual review of the record. After editing data of 
each province and considering in mind that for deleting 
of repeated cases, similar cases should also be the same 
as morphology, topography, identity and demographic 
information; deletion of the repeated cases would be done 
separately in each province and finally in all over country 
by experienced manual reviewers. 
 Data extracted were studied based on the number 
of cases and standardized incidence rates for box sexes 
and sex ratio. Standardized incidence rates were directly 
calculated based on the world standard population. Data 
was analyzed using STATA (version 12) software. To 
calculate the annual percentage change (APC) and trend, 
Join point 4.1.1.1 software was applied. The significance 
level was considered as 0.05. Common cancers were 
defined as the number of reported cases and standardized 
incidence rates. 
Results 
In this study, there were 7,767 registered cases of 
cancer during 6 years studied. Of the total cases registered, 
59.1% (4,592 cases) were men and 40.9% (3,175 cases) 
occurred in women. The sex ratio, according to the number 
of cancer cases, (male to female) for all cancers was 1.45. 
The highest number of cancer cases (704 cases) was seen 
in women in 2009 and the greatest number of cancer cases 
(1,067 cases) was observed in 2008 in men. The total 
number of cancer cases was 781 cases in 2004 and the 
number was increased to 1,635 cases in 2009, as changes 
in cases were more than twice and APC was equal to 109.3. 
The Age-Standardized Rate (ASR) was increased 
Figure 1. Join Point Analysis of Incidence Cancer in 
Men in Hamedan, Iran, 2004 - 2009. ASR (W) – age-
standardized rate per 100 000 (using world standard population)
Figure 2. Join Point Analysis of Incidence Cancer in 
Women in Hamedan, Iran, 2004 - 2009. ASR (W) – age-
standardized rate per 100 000 (using world standard population)
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from 72.88 to 132.03 in males between 2004 and 2009 
and the increasing trend was significant according to 
mean percentage changes of 14.52 (CI: 6-23.8, p<0.001) 
(Figure1). In females, the rate was increased from 48.17 
to 114.98 during 6 years of the study so that the increasing 
trend was significant considering mean percentage 
changes of 17.28 (CI: 7.6-27.9, p<0.001) (Figure 2). The 
cancer incidence trend is shown in Table 1 by three-year 
periods (2004-2006, 2007-2009). 
Mean age-standardized incidence rate was 111.81 
per 100,000 people in males and 88.12 per 100,000 
people in females. Overall, the most common cancers in 
both sexes during six years studied were skin, stomach, 
breast, bladder, and leukemia, respectively. The most 
common cancers were breast, skin, stomach, colorectal, 
and leukemia in women during 6 years, respectively, but 
in men skin stomach, bladder, leukemia, and prostate 
cancers, respectively (Figure 3).
Discussion
In this study, common cancers were investigated by 
sex in the province of Hamadan during 2004 and 2009. 
The largest number of cases occurred in men (59.1% 
vs.40.9%). In the province of eastern Azerbaijan, located 
in North West of Iran, the greatest number of cases was 
seen in men (63.01% vs.336.67) between 2007 and 
2001(Ferlay J, 2013). As well, the rate was more in males 
than females in Europe (53% vs.47%)(Fateh M, 2013). In 
our study, mean percentage of 14.52 in men and 17.28 in 
women indicated significant increases in trend of disease 
(p<0.001). Another study in Iran showed that APC was 
12.4%(Siegel, 2014) while in United States (U.S), the 
incidence rate has slightly decreased in men (6% per year) 
but it has been constant in women during 2006 to 2011 
(Mousavi et al., 2009). The incidence of all cancers in 
developed countries than in developing countries in both 
men and women is nearly double while the rate of death 
from cancer in developed countries, only 21% in males 
and 2% higher in women. This inequality in patterns of 
incidence and mortality between developed regions and 
underdeveloped regional differences in the prevalence 
and distribution of risk factors, diagnostic methods 
and availability and use of health care services reflects 
(Mousavi, 2009). 
Highest increase in cancer cases was seen in men 
and women in 2008, can be attributed to changes in the 
cancer registry system in the country because reports on 
cancer cases was made based on pathology reports, but 
reports of cancer cases were done as population based 
from 2008. According to improving the registry system, 
the probability of not reporting cases was very low. 
Therefore, an increased peak was observed in men and 
women in 2008. Another study in Iran also showed that 
the sex ratio (male to female) was 14.5 while the ratio 
for all cancers was 1/1.2 in the country (Mousavi, 2009). 
Table 1. Join Point Analyses of Cancers Incidence in Hamedan, Iran, 2004 - 2009, with the Estimated Annual 
Percent Change (APC) and 95% Confidence Intervals 
 Trend 1 Trend 2 Full Range 
 years APC 95% CI years APC 95% CI years AAPC 95% CI
Male 2004- 2007 19.1* 6.8 to 32.8 2007- 2009 7.2 -13.8 to 33.3 2004- 2009 14.2* 12.3 to 16.1
Female 2006- 2009 33.1 -69.8 to 486.3 2006- 2009 8.8 -48.1 to 128.5 2004- 2009 18.0* 5.2 to 32.2
Figure 3. Five Common Cancer and Number of Cases for by Sex and Both Sex in Hamedan, Iran (2004 – 2009)
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ASR was increased from 72.88 to 132.03 in males and 
from 48.17 to 114.98 between 2004 and 2009, which is 
related to lifestyle changes such as increasing consumption 
of fast foods, fatty foods, and sedentary lifestyle. Mean 
age-standardized incidence rate was 111.81 per 100,000 
people in males and 88.12 per 100,000 people in females, 
which was lower than ASR in Korea (345.1 in males and 
300.9 in females per 100,000 people) and Serbia (307.2 in 
males and 256.4 in males) (Jung et al., 2012b; Mihajlovic 
et al., 2013). The most common cancer was skin in men 
(ASR=22.44), but a study in Shahrood, a city in Iran, 
showed skin was the second most common cancer in 
men (Mousavi et al., 2009). While it was not among the 
fifth common cancers in Korea, China, Europe, Serbia 
(Mousavi et al., 2009; Jung et al., 2012a; Ferlay, 2013). In 
other words, Iranian men do not protection actions against 
sun’s ultraviolet radiation. Hence, notification is required. 
In 2008 989,600 new cases and 738,000 deaths due to 
stomach cancer occurred in the world. More than 70% of 
new cases and deaths are in developing countries. The rate 
of gastric cancer in men is about twice that of women. The 
highest incidence of gastric cancer in East Asia, Eastern 
Europe and South America and lowest in North America 
and many parts of Africa. The geographical differences 
reflect differences in dietary patterns, particularly in 
European countries, the prevalence of H. pylori infection 
Ferlay and Steliarova-Foucher, 2010). Stomach cancer 
was the second most common cancer in men in Hamadan 
(ASR=14.88), but the cancer is the first common cancer 
in Iranian men (ASR=15) (Ferlay and Steliarova-Foucher, 
2010). Another study in Iran showed that stomach is the 
first common cancer in males (Mousavi, 2009), similar to 
Korea (Ferlay et al., 2013). It was the fifth cancer in Europe 
(Xie et al., 2012). Bladder cancer (ASR=12.73) was the 
third common cancer in men in Hamadan and the forth in 
men in Europe and Serbia (ASR=16.2) (Mousavi et al., 
2009; Jung et al., 2012a). Also the incidence of stomach 
cancer is increasing in Iran, so further epidemiological 
studies into the etiology and early detection are essential 
(Almasi et al., 2015).
In this study, breast cancer was the first common 
cancer in women (ASR=17.98), which was lower than 
the country (ASR=24) (Mousavi et al., 2009; Enayatrad, 
2015). In other studies, the cancer was the first in women 
(Mousavi, 2009; Razavi, 2009; Jung, 2012b; Siegel, 2014; 
Enayatrad M, 2015). The overall incidence of breast 
cancer in Western countries, Northern Europe, Australia, 
New Zealand and North America, the average in South 
America and North Africa and in sub-Saharan Africa and 
Asia is low. It was much lower in Iranian females than 
developed countries. This may be due to lifestyle and 
early detection facilities. In Iran, according to the high 
cost of diagnostic procedures, including mammography, 
and unavailability for everybody, women over 40 years do 
not regularly benefit from the diagnostic methods, which 
used only in emergency cases. Therefore, the factor can 
affect cancer statistics.
In our study, the second common cancer was skin in 
women (ASR=13.5) but it was not considered important 
cancers in females (Mousavi et al., 2009; Jung et al., 
2012a; Ferlay et al., 2013; Razi et al., 2015). Given Iranian 
women’s coverage and their lower exposure, it is expected 
that skin cancer incidence rate is low but I Hamadan the 
cancer was the second common cancer in females. As a 
result, it is necessary to conduct education programs for 
skin care against ultraviolet radiation. 
In this study, the third common cancer was stomach 
in women (ASR=6.88). It is the fourth in Iranian females 
(ASR=6.65), similar to Korea (24.7) (Jung et al., 2012b).
Colorectal cancer is the third most common cancer 
in men and the second most common cancer in women, 
more than 2.1 million new cases and 608,700 deaths 
due to colorectal cancer occurred in 2008. The highest 
incidence rates in Australia, New Zealand, Europe and 
North America, while the lowest is in Africa and South and 
Central Asia. Colorectal cancer was the fourth common 
cancer in females in Hamadan (ASR=6.02), lower than the 
country (ASR=8.17). The fifth common cancer in women 
studied was leukemia (ASR=5.47). The cancer was not 
among five common cancers in all women (Mousavi et 
al., 2009; Razavi et al., 2009; Jung et al., 2012b; Ferlay 
et al., 2013). 
The differences between incidence rates and the type 
of common cancers in this study compared with other 
studies can be due to racial and environmental differences, 
and lifestyle. It is necessary to carry out other studies on 
identifying effective risk factors, prevention and control 
of cancers.
In conclusion, our finding revealed that the cancer 
incidence was more in men that women in this region and 
associated with increasing trend in both sexes. Planning 
regarding education in prevention of exposure to risk 
factors and control strategies is required to decrease the 
incidence cases. Screening program for common cancers 
in older age groups can be helpful.
References
Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology 
characteristics and trends of incidence and morphology 
of stomach cancer in Iran. Asian Pac J Cancer Prev, 16, 
2757-61.
Bryere J DO, Bouvier V, Colonna M, Guizard A-V, Troussard 
X, et al (2014). Socioeconomic environment and cancer 
incidence: a French population-based study in Normandy. 
BMC Cancer, 14, 87.
Chen W ZR, Zhang S, Zhao P, Li G, Wu L, et al (2013). The 
incidences and mortalities of major cancers in China, 2009. 
Chinese J Cancer, 32, 106-12.
Enayatrad M SH (2015). An investigation of changing patterns 
in breast cancer incidence trends among Iranian women. 
Quarterly J Sabzevar University of Medical Sciences, 22, 
27-35.
Fateh M EM ( 2013). Cancer incidence and trend analysis in 
Shahroud, Iran, 2000-2010. Iranian J Cancer Prev, 6, 85-94.
Ferlay J, Steliarova-Foucher E (2010). Estimates of cancer 
incidence and mortality in Europe in 2008. European J 
Cancer, 46, 765-81.
Ferlay J S-FE, Lortet-Tieulent J, Rosso S, et al ( 2013). Cancer 
incidence and mortality patterns in Europe: Estimates for 
40 countries in 2012. European J Cancer, 49, 1374-403.
Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H 
(2015). Incidence and mortality of breast cancer and their 
relationship to development in asia. Asian Pac J Cancer 
Prev, 16, 6081-7.
Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 7193
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.16.7189
Incidence, Trends and Epidemiology of Cancers in North West Iran 
Goya M, (2007). Iranian annual cancer registration report 
2005/2006. ministry of health and medical education, health 
deputy. center for disease control and prevention 2007. [In 
Persian]. Tehran, Iran.
Harirchi I KS, Karbakhsh M, Chegini N, et al (2011). Twenty 
years of breast cancer in Iran: downstaging without a formal 
screening program. Annals Oncol, 22, 93-7.
Jemal A CM, DeSantis C, Ward EM (2010). Global patterns 
of cancer incidence and mortality rates and trends. Cancer 
Epidemiology Biomarkers & Prevention, 19, 1893-907.
Jung K-W PS, Kong H-J, Won Y-J, et al (2012a). Cancer statistics 
in Korea: incidence, mortality, survival, and prevalence in 
2009. Cancer Research and Treatment, 44, 11-24.
Jung K-W PS, Won Y-J, Kong H-J, et al (2012b). Prediction 
of cancer incidence and mortality in Korea, 2012. Cancer 
Research and Treatment, 44, 25-31.
Keyghobadi N RH, Mohammadian-Hafshejani A, Enayatrad 
M, Salehiniya H (2015). Epidemiology and trend of cancers 
in the province of Kerman: southeast of Iran. Asian Pac J 
Cancer Prev, 16, 1409-13.
Kolahdoozan S, Sadjadi A, Radmard AR, et al (2010). Five 
common cancers in Iran. Arch Iran Med, 13, 143-6.
Mihajlovic J PP, Miladinov-Mikov M, Zivkovic S, Postma MJ 
(2013). Cancer incidence and mortality in Serbia 1999-2009. 
BMC Cancer, 13, 1471-2407.
Mousavi SM GM, Ramazani R, Davanlou M, Hajsadeghi N, 
Seddighi Z (2009). Cancer incidence and mortality in Iran. 
Ann Oncol, 20, 556-63.
Neda Amoori MM, Maria Cheraghi (2014). Incidence of Cancers 
in Kuzestan Province of Iran: Trend from 2004 to 2008. 
Asian Pac J Cancer Prev, 15, 8345-49.
Razavi SE AH, Haghazali M, Nadali F, Ramazani R, Dabiri E, 
et al (2009). The most common cancers in Iranian women. 
Iranian J Public Health, 38, 109-12.
Razi S, Rafiemanesh H, Ghoncheh M, et al (2015). Changing 
trends of types of skin cancer in Iran. Asian Pac J Cancer 
Prev, 16, 4955-8.
Saeid Razi, Mostafa Enayatrad, abdollah Mohammadian-
Hafshejani, et al ( 2015). The Epidemiology of Skin Cancer 
and its Trend in Iran. Intern J Prev Med, 6, 65.
Siegel R MJ, Zou Z, Jemal A (2014). Cancer statistics, 2014. 
CA: A Cancer J Clinicians, 64, 9-29.
Thun MJ DJ, Center MM, Jemal A, Ward EM (2010). The global 
burden of cancer: priorities for prevention. Carcinogenesis, 
31, 100-10.
Xie W-C CM-H, Mak K-C, Chan W-T, He M. (2012). Trends in 
the incidence of 15 common cancers in Hong Kong. Asian 
Pac J Cancer Prev, 13, 3911-6.
Zanetti R SI, Sacchetto L, Binder-Foucard F, Bordoni A, Coza 
D, et al. Completeness and timeliness: Cancer registries 
could/should improve their performance. European Journal 
of Cancer.
